6368 related articles for article (PubMed ID: 3257967)
41. Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor.
Schleef RR; Bevilacqua MP; Sawdey M; Gimbrone MA; Loskutoff DJ
J Biol Chem; 1988 Apr; 263(12):5797-803. PubMed ID: 3128548
[TBL] [Abstract][Full Text] [Related]
42. Plasminogen activator inhibitor types 1 and 2 in human trophoblasts. PAI-1 is an immunocytochemical marker of invading trophoblasts.
Feinberg RF; Kao LC; Haimowitz JE; Queenan JT; Wun TC; Strauss JF; Kliman HJ
Lab Invest; 1989 Jul; 61(1):20-6. PubMed ID: 2473276
[TBL] [Abstract][Full Text] [Related]
43. Isolation of multiple types of plasminogen activator inhibitors from vascular smooth muscle cells.
Laug WE; Aebersold R; Jong A; Rideout W; Bergman BL; Baker J
Thromb Haemost; 1989 Jun; 61(3):517-21. PubMed ID: 2799763
[TBL] [Abstract][Full Text] [Related]
44. [Type 1 plasminogen activator inhibitor: its role in biological reactions].
Mimuro J
Rinsho Ketsueki; 1991 May; 32(5):487-9. PubMed ID: 1870265
[TBL] [Abstract][Full Text] [Related]
45. [Production and secretion of the plasminogen activator inhibitor type-2 in a leukemia cell line].
Niiya K
Rinsho Ketsueki; 1991 May; 32(5):490-6. PubMed ID: 1870266
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of plasminogen activators by conditioned medium of human hepatocytes and hepatoma cell line Hep G2.
Sprengers ED; Princen HM; Kooistra T; van Hinsbergh VW
J Lab Clin Med; 1985 Jun; 105(6):751-8. PubMed ID: 2987382
[TBL] [Abstract][Full Text] [Related]
47. Dexamethasone inhibition of tissue-type plasminogen activator (tPA) activity: paradoxical induction of both tPA antigen and plasminogen activator inhibitor.
Gelehrter TD; Sznycer-Laszuk R; Zeheb R; Cwikel BJ
Mol Endocrinol; 1987 Jan; 1(1):97-101. PubMed ID: 3137452
[TBL] [Abstract][Full Text] [Related]
48. Heparin stimulates fibrinolysis in mesothelial cells by selective induction of tissue-plasminogen activator but not plasminogen activator inhibitor-1 synthesis.
Grulich-Henn J; Preissner KT; Müller-Berghaus G
Thromb Haemost; 1990 Nov; 64(3):420-5. PubMed ID: 2128972
[TBL] [Abstract][Full Text] [Related]
49. Plasminogen activator-specific inhibitors in mouse macrophages: in vivo and in vitro modulation of their synthesis and secretion.
Wohlwend A; Belin D; Vassalli JD
J Immunol; 1987 Aug; 139(4):1278-84. PubMed ID: 3112228
[TBL] [Abstract][Full Text] [Related]
50. Binding of type 1 plasminogen activator inhibitor to the extracellular matrix of cultured bovine endothelial cells.
Mimuro J; Loskutoff DJ
J Biol Chem; 1989 Mar; 264(9):5058-63. PubMed ID: 2494180
[TBL] [Abstract][Full Text] [Related]
51. The majority of type 1 plasminogen activator inhibitor associated with cultured human endothelial cells is located under the cells and is accessible to solution-phase tissue-type plasminogen activator.
Schleef RR; Podor TJ; Dunne E; Mimuro J; Loskutoff DJ
J Cell Biol; 1990 Jan; 110(1):155-63. PubMed ID: 2104856
[TBL] [Abstract][Full Text] [Related]
52. Kinetic analysis of the interactions between plasminogen activator inhibitor 1 and both urokinase and tissue plasminogen activator.
Hekman CM; Loskutoff DJ
Arch Biochem Biophys; 1988 Apr; 262(1):199-210. PubMed ID: 3128176
[TBL] [Abstract][Full Text] [Related]
53. The addition of endothelial cell growth factor and heparin to human umbilical vein endothelial cell cultures decreases plasminogen activator inhibitor-1 expression.
Konkle BA; Ginsburg D
J Clin Invest; 1988 Aug; 82(2):579-85. PubMed ID: 3136192
[TBL] [Abstract][Full Text] [Related]
54. Affinity purification of active plasminogen activator inhibitor-1 (PAI-1) using immobilized anhydrourokinase. Demonstration of the binding, stabilization, and activation of PAI-1 by vitronectin.
Wun TC; Palmier MO; Siegel NR; Smith CE
J Biol Chem; 1989 May; 264(14):7862-8. PubMed ID: 2470735
[TBL] [Abstract][Full Text] [Related]
55. A plasminogen activator inhibitor (PAI-2) circulates in two molecular forms during pregnancy.
Booth NA; Reith A; Bennett B
Thromb Haemost; 1988 Feb; 59(1):77-9. PubMed ID: 3129811
[TBL] [Abstract][Full Text] [Related]
56. Association of a plasminogen activator inhibitor (PAI-1) with the growth substratum and membrane of human endothelial cells.
Levin EG; Santell L
J Cell Biol; 1987 Dec; 105(6 Pt 1):2543-9. PubMed ID: 3121634
[TBL] [Abstract][Full Text] [Related]
57. Retinal pigment epithelial cells produce a latent fibrinolytic inhibitor that is antigenically and biochemically related to type 1 plasminogen activator inhibitor produced by vascular endothelial cells.
Campochiaro PA; Mimuro J; Sugg R; Loskutoff DJ
Exp Eye Res; 1989 Aug; 49(2):195-203. PubMed ID: 2504614
[TBL] [Abstract][Full Text] [Related]
58. Phorbol ester induces the biosynthesis of glycosylated and nonglycosylated plasminogen activator inhibitor 2 in high excess over urokinase-type plasminogen activator in human U-937 lymphoma cells.
Genton C; Kruithof EK; Schleuning WD
J Cell Biol; 1987 Mar; 104(3):705-12. PubMed ID: 3102504
[TBL] [Abstract][Full Text] [Related]
59. Plasminogen activator-specific inhibitors produced by human monocytes/macrophages.
Wohlwend A; Belin D; Vassalli JD
J Exp Med; 1987 Feb; 165(2):320-39. PubMed ID: 2434595
[TBL] [Abstract][Full Text] [Related]
60. Glucocorticoids stimulate plasminogen activator production by rat granulosa cells.
Wang C; Leung A
Endocrinology; 1989 Apr; 124(4):1595-601. PubMed ID: 2784380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
